Advances in Biological Chemistry

Advances in Biological Chemistry

ISSN Print: 2162-2183
ISSN Online: 2162-2191
www.scirp.org/journal/abc
E-mail: abc@scirp.org
"The Effect of Bergamot-Derived Polyphenolic Fraction on LDL Small Dense Particles and Non Alcoholic Fatty Liver Disease in Patients with Metabolic Syndrome"
written by Micaela Gliozzi, Cristina Carresi, Vincenzo Musolino, Ernesto Palma, Carolina Muscoli, Cristiana Vitale, Santo Gratteri, Giuseppe Muscianisi, Elzbieta Janda, Saverio Muscoli, Francesco Romeo, Salvatore Ragusa, Rocco Mollace, Ross Walker, James Ehrlich, Vincenzo Mollace,
published by Advances in Biological Chemistry, Vol.4 No.2, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Bergamot polyphenols improve Dyslipidemia and pathophysiological features in a Mouse Model of non-Alcoholic fatty Liver Disease
2020
[2] The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease
2020
[3] Lipid-lowering nutraceuticals update on scientific evidence
2020
[4] The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: a clinical review
2020
[5] Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years
2020
[6] The Effect of Natural Antioxidants in the Development of Metabolic Syndrome: Focus on Bergamot Polyphenolic Fraction
2020
[7] Valorization of pomelo (Citrus grandis Osbeck) peel: A review of current utilization, phytochemistry, bioactivities, and mechanisms of action
2020
[8] Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review
2020
[9] Hypoglycemic and Hypolipemic Effects of a New Lecithin Formulation of Bergamot Polyphenolic Fraction: A Double Blind, Randomized, Placebo-Controlled Study
2019
[10] Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis Development
2019
[11] The effect of bergamot polyphenolic fraction on lipid transfer protein system and vascular oxidative stress in a rat model of hyperlipemia
2019
[12] Effects of bergamot (Citrus bergamia) peel oil-supplemented diets on growth performance, haematology and serum biochemical parameters of Nile tilapia (Oreochromis niloticus)
Fish physiology and biochemistry, 2019
[13] Nowe możliwości terapii osób z zespołem metabolicznym
2019
[14] Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols
2019
[15] Detailed Phytochemical Characterization of Bergamot Polyphenolic Fraction (BPF) by UPLC-DAD-MS and LC-NMR
2019
[16] Effect of bergamot on lipid profile in humans: A systematic review
2019
[17] New treatment options for patients with metabolic syndrome
2019
[18] Turunçgil Flavonoidlerinin Kardiyovasküler Sağlık Üzerine Etkileri
2019
[19] EFECTO DE LA BERGAMOTA SOBRE EL PERFIL LIPÍDICO EN HUMANOS: REVISIÓN SISTEMÁTICA
2019
[20] Der fruchtige Schutz des Gefäßsystems
2019
[21] Expert group consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy on the place of a standardized bergamot …
2018
[22] Stanowisko grupy ekspertów wsparte przez Sekcję Farmakoterapii Sercowo-Naczyniowej Polskiego Towarzystwa Kardiologicznego dotyczące miejsca …
2018
[23] Modulation of Nitric Oxide Synthases by oxyLDL: Role in Vascular Inflammation and Atherosclerosis Development
2018
[24] Frazione polifenolica del bergamotto per il trattamento della sindrome metabolica nella schizofrenia: uno studio pilota
2018
[25] Stanowisko grupy ekspertów wsparte przez Sekcję Farmakoterapii Sercowo-Naczyniowej Polskiego Towarzystwa Kardiologicznego dotyczące miejsca standaryzowanej kompozycji polifenoli z bergamoty w terapii dyslipidemii oraz jej innego potencjalnego zastosowania
Folia Cardiologica, 2018
[26] An update on the safety of nutraceuticals and effects on lipid parameters
Expert Opinion on Drug Safety, 2018
[27] The Role of Nutraceuticals in Statin Intolerant Patients
2018
[28] Anti-oxidant effect of bergamot polyphenolic fraction counteracts doxorubicin-induced cardiomyopathy: Role of autophagy and c-kitposCD45negCD31neg cardiac stem cell activation
Journal of Molecular and Cellular Cardiology, 2018
[29] Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Nutrition Reviews, 2017
[30] Nutraceuticals as an important part of combination therapy in dyslipidaemia
Current Pharmaceutical Design, 2017
[31] Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach
Food & Function, 2017
[32] Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study
Frontiers in Pharmacology, 2017
[33] Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics: a pilot study
The Journal of Nutritional Biochemistry, 2017
[34] Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients …
2017
[35] STAY CONNECTED…
2016
[36] Synergistic in vitro antioxidant activity and observational clinical trial of F105, a phytochemical formulation including Citrus bergamia, in subjects with moderate cardiometabolic risk factors
Canadian Journal of Physiology and Pharmacology, 2016
[37] Essential oil components of orange peels and antimicrobial activity
Journal of Apicultural Research, 2016
[38] Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study
Frontiers in Pharmacology, 2016
[39] Bergamont Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study
Frontiers in Pharmacology, 2016
[40] The treatment of hyperuricemia
International journal of cardiology, 2015
[41] Studies on the protective role of Bergamot polyphenols in doxorubicin-induced cardiotoxicity
PharmaNutrition, 2015
[42] The effect of bergamot polyphenolic fraction in patients with non alcoholic liver steato-hepatitis and metabolic syndrome
PharmaNutrition, 2015
[43] The effect of bergamot on dyslipidemia
Phytomedicine, 2015
[44] Taking Back Control
2014
[45] Bergamot Polyphenols: Pleiotropic Players in the Treatment of Metabolic Syndrome
J Metabolic Syndome, 2014
Free SCIRP Newsletters
Copyright © 2006-2021 Scientific Research Publishing Inc. All Rights Reserved.
Top